Management of oxytocininduced hyperstimulation

a. The most common adverse effect of hyperstimulation is fetal heart rate deceleration associated with uterine hyperstimulation. Stopping or decreasing the dose of oxytocin may correct the abnormal pattern.

b. Additional measures may include changing the patient to the lateral decubitus position and administering oxygen or more intravenous fluid.

c. If oxytocin-induced uterine hyperstimulation does not respond to conservative measures, intravenous terbutaline (0.125-0.25 mg) or magnesium sulfate (2-6 g in 10-20% dilution) may be used to stop uterine contractions.

References: See page 184.

0 0

Post a comment